The DOI matches its Crossref record; 429 of the 433 references it cites were found in a registry or an index.
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
Abstract
The purpose of the present review is to describe the place of endogenous kinins, mainly bradykinin (BK) and des-Arg(9)-BK in the kallikrein-kininogen-kinin system, to review and compare the different analytical methods reported for the assessment of endogenous kinins, to explain the difficulties and the pitfalls for their quantifications in biologic samples and finally to see how the results obtained by these methods could complement and extend the pharmacological evidence of their pathophysiological role.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kininase I enzymes normally transform a minute fraction (3.5%) of BK into its active metabolite, des-arginine 9 -bradykinin (des-Arg 9 -BK) (Blais et al. 2000).”
From A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. (2005) · cites this paper as Blais et al. 2000
In the citing paper
“In the presence of ACE inhibition, however, kininase I activity is increased (transforms 28% of BK into des-Arg 9 -BK), and APP acts as the major metabolizing enzyme of both BK and desArg 9 -BK (Blais et al. 2000).”
From A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. (2005) · cites this paper as Blais et al. 2000
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Pharmacology of bradykinin and related kinins.
Regoli, D., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,892
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Myocardial infarct size and ventricular function in rats.
Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C., Fletcher, P. J., Spadaro, J., Kloner, R. A., & Braunwald, E. (1979) · Circulation Research · doi:10.1161/01.res.44.4.503 · Cited by 1,281
THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME
Skeggs, L. T., Kahn, J. R., & Shumway, N. P. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.3.295 · Cited by 1,032
e Silva, M. R., Beraldo, W. T., & Rosenfeld, G. (1949) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1949.156.2.261 · Cited by 825
Cell-Associated Plasminogen Activation: Regulation and Physiological Functions
Saksela, O., & Rifkin, D. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.000521 · Cited by 818
Research works printed but not linked: 13
- Abelous, 1909, Les substances hypotensives de l’urine humaine normale, C R Soc Biol (Paris), 66, 511
- Blais, 1997, Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin, Am J Physiol, 273, H2263
- Elliott, 1959, The isolation of bradykinin, Biochem J, 74, 15P
- Ferreira, 1967, The disappearance of bradykinin and eledoisin in the circulation and vascular beds of cats, Br J Pharmacol, 30, 417
- Frey, 1926, Zusammenhänge zwischen Herzarbeit und Nierentätigkeit, Langenbecks Arch Klin Chir, 142, 663
- Raut, 1999, Bradykinin metabolism in the postinfarcted rat heart, Am J Physiol, 276, H1769
- Ryan, 1994, Characterization of rat pulmonary vascular aminopeptidase P in vivo, J Pharmacol Exp Ther, 269, 941
- Salgado, 1986, Blood kinin in one-kidney, one clip hypertensive rats, Hypertension, 8, I110
- Schmaier, 1998, Plasma contact activation, Biol Res, 31, 251
- van Gilst, 1986, Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors, J Cardiovasc Pharmacol, 8, 722
- Yang, 1971, Characterization of a dipeptide hydrolase (kininase II, J Pharmacol Exp Ther, 177, 291
- Zhu, 1995, Bradykinin improves postischaemic recovery in the rat heart, Cardiovasc Res, 29, 658, 10.1016/0008-6363(96)88637-8 · doi:10.1016/0008-6363(96)88637-8
- Zuzack, 1996, Evidence of a bradykinin B1 receptor in human ileum, J Pharmacol Exp Ther, 277, 1337
Cited by
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
“…in the side effects of ACE inhibitors (nonproductive cough, rare but life-threatening angioedema, hypotension in patients subjected to extracorporeal circulation) may be significant and has been discussed elsewhere (Fox et al., 1996; Blais et al., 2000; Mukae et al., 2000; Scholzen et al., 2003).”
BackgroundMethodSelf-citationThe Kallikrein-Kinin System: Current and Future Pharmacological Targets
Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.srj05001x · Cited by 457
Self-citationBradykinin receptor ligands: therapeutic perspectives
Marceau, F., & Regoli, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1522 · Cited by 374
Self-citationVasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease?
Corti, R., Burnett Jr, J. C., Rouleau, J. L., Ruschitzka, F., & Lüscher, T. F. (2001) · Circulation · doi:10.1161/hc4001.097191 · Cited by 300
Self-citation
Metadata
- Authors
- Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A.
- Affiliations
- Université de Montréal (CA)
- Centre hospitalier universitaire de Québec (CA)
- University Health Network (CA)
- Corresponding author
- Adam, Albert
- Venue
- Peptides
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 21
- Issue
- 12
- Pages
- 1903-1940
- ISSN
- 0196-9781 (ISSN-L)
- OpenAlex
- W1967102304
- Cited by
- 135
- References
- 433
- Citations by year
- 2024: 2 · 2023: 8 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 1 · 2013: 3 · 2012: 5
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Peptides (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- bradykinin, des-Arg9-bradykinin, analytical methods, biological specimen
- MeSH terms
- Animals, Antihypertensive Agents, Humans, Kallikreins, Kinetics, Kininogens, Kinins, Models, Biological, Time Factors, Tissue Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. https://app.cochat.ai/papers/10.1016/s0196-9781(00)00348-x
- The paper
- Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000). The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides. https://doi.org/10.1016/s0196-9781(00)00348-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.